IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 133 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q3 2018. The put-call ratio across all filers is 0.33 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $1,317,000 | -71.9% | 137,500 | -27.7% | 0.00% | -50.0% |
| Q3 2021 | $4,692,000 | -82.4% | 190,300 | -81.4% | 0.00% | -82.6% |
| Q2 2021 | $26,656,000 | +1108.9% | 1,024,400 | +1369.8% | 0.02% | +1050.0% |
| Q1 2021 | $2,205,000 | -18.2% | 69,696 | +20.0% | 0.00% | 0.0% |
| Q4 2020 | $2,696,000 | +294.7% | 58,069 | +179.9% | 0.00% | – |
| Q3 2020 | $683,000 | -12.9% | 20,745 | -27.7% | 0.00% | -100.0% |
| Q2 2020 | $784,000 | -33.6% | 28,700 | -32.7% | 0.00% | 0.0% |
| Q4 2019 | $1,180,000 | – | 42,637 | +426270.0% | 0.00% | – |
| Q2 2019 | $0 | -100.0% | 10 | -94.3% | 0.00% | – |
| Q4 2018 | $2,000 | -97.4% | 174 | -97.5% | 0.00% | – |
| Q3 2018 | $77,000 | +2.7% | 6,885 | -26.8% | 0.00% | – |
| Q4 2017 | $75,000 | – | 9,408 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 3,876,600 | $127,618,000 | 11.48% |
| Fairmount Funds Management LLC | 596,890 | $19,650,000 | 8.32% |
| Ghost Tree Capital, LLC | 575,000 | $18,929,000 | 5.47% |
| Perceptive Advisors | 10,085,632 | $332,019,000 | 4.85% |
| Avoro Capital Advisors LLC | 9,536,039 | $313,926,000 | 4.46% |
| FRAZIER MANAGEMENT LLC | 1,312,999 | $43,224,000 | 3.88% |
| ACUTA CAPITAL PARTNERS, LLC | 315,000 | $10,370,000 | 2.82% |
| Orbimed Advisors | 6,645,100 | $218,757,000 | 2.75% |
| QVT Financial LP | 572,971 | $18,862,000 | 2.30% |
| Prosight Management, LP | 120,606 | $3,970,000 | 1.89% |